XORTX Therapeutics Inc. (XRTX)
NASDAQ: XRTX · Real-Time Price · USD
0.6000
+0.0094 (1.59%)
At close: Dec 19, 2025, 4:00 PM EST
0.5921
-0.0079 (-1.32%)
After-hours: Dec 19, 2025, 5:32 PM EST
XORTX Therapeutics Market Cap
XORTX Therapeutics has a market cap or net worth of $4.3 million as of December 19, 2025. Its market cap has decreased by -15.52% in one year.
Market Cap
4.30M
Enterprise Value
3.15M
1-Year Change
-15.52%
Ranking
Category
Stock Price
$0.60
Market Cap Chart
Since January 11, 2018, XORTX Therapeutics's market cap has decreased from $25.10M to $4.30M, a decrease of -82.88%. That is a compound annual growth rate of -19.95%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 15, 2025 | 4.30M | 5.13% |
| Dec 30, 2024 | 4.09M | -6.85% |
| Dec 29, 2023 | 4.39M | -63.14% |
| Dec 30, 2022 | 11.91M | -53.60% |
| Dec 31, 2021 | 25.66M | 177.78% |
| Dec 31, 2020 | 9.24M | 19.02% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2018 | Upgrade Pro | Upgrade Pro |
| Jan 11, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 959.35B |
| Johnson & Johnson | 497.21B |
| AbbVie | 400.88B |
| UnitedHealth Group | 296.59B |
| AstraZeneca | 283.55B |
| Novartis AG | 261.76B |
| Merck & Co. | 250.91B |
| Abbott Laboratories | 218.14B |